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Poor regeneration of severed axons in the central nervous system (CNS) limits functional
recovery. Regeneration failure involves interplay of inhibitory environmental elements and
the growth state of the neuron. To find internal changes in gene expression that might
overcome inhibitory environmental cues, we compared several paradigms that allow
growth in the inhibitory environment. Conditions that allow axon growth by axotomized
and cultured dorsal root ganglion (DRG) neurons on CNS myelin include immaturity (the
first few postnatal days), high levels of cyclic adenosine mono phosphate (cAMP), and
conditioning with a peripheral nerve lesion before explant. This shift from inhibition to
growth depends on transcription. Seeking to understand the transcriptome changes that
allow axon growth in the CNS, we collaborated with the Marie Filbin laboratory to identify
several mRNAs that are functionally relevant, as determined by gain- and loss-of-function
studies. In this Perspective, we review evidence from these experiments and discuss the
merits of comparing multiple regenerative paradigms to identify a core transcriptional
program for CNS axon regeneration.
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Regenerative Paradigms to Identify Genes
To boost axon growth in the Central Nervous System (CNS), one strategy is to alter the CNS
environment, to make it more conducive to growth by eliminating growth inhibitors or by adding
a growth substrate, such as cells or material scaffolds. The other general approach is to increase
the regenerative potential of neurons so that they may be able to grow in spite of the inhibitory
environment. We considered the interplay of these two factors by asking which changes in gene
expression could allow axonal regrowth in the inhibitory CNS environment. This Perspective is
intended to review our approach and is not intended as a comprehensive review of regeneration-
associated genes, which has been done by others, including in this issue (Ma and Willis).
One of the most actively investigated paradigms of regeneration is the conditioning lesion
model. Axotomy of the peripheral dorsal root ganglion (DRG) axon normally results in
regeneration while injury of the central axon does not. If the peripheral branch is injured
first, however, and the central axon is injured 1 day to 2 weeks afterwards, the central axons
regenerate to a much greater extent (e.g., McQuarrie and Grafstein, 1973; Richardson and
Issa, 1984; Chong et al., 1999; Neumann and Woolf, 1999). The peripheral conditioning lesion
induces changes in the axonal growth capacity of the injured neuron. The change in axonal
growth state is likely due to induction of gene products associated with regenerative function,
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often called regeneration-associated genes or RAGs (Lankford
et al., 1998). Smith and Skene (1997) demonstrated that cultured
DRGs, which normally extend short, highly branched axons, will
extend long, sparsely branched axons after a peripheral lesion.
The switch from ‘‘arborizing’’ to ‘‘elongating’’ growth requires
transcription and is blocked by addition of the transcription
factor IIH (TFIIH)-associated protein kinase inhibitor 5,6-
Dichloro-1-β-D-ribofuronosylbenzimidozole (DRB; Yankulov
et al., 1995; Smith and Skene, 1997).
The conditioning lesion paradigm was used as an early
strategy to screen for candidate gene products associated
with re-growth. A prototypical RAG is GAP43. GAP43 was
originally identified in a two-dimensional protein electrophoresis
comparing DRGs with and without sciatic nerve injury (Skene
and Willard, 1981). GAP43 is primarily localized to the growth
cone and is elevated in other growth states, such as during
development (Skene, 1989; Benowitz and Routtenberg, 1997),
and recovery of function after injury is correlated with induction
of GAP43 (Skene and Willard, 1981; Skene, 1989; Gispen et al.,
1991; Plunet et al., 2002). Furthermore, overexpression of GAP43
and cytoskeleton-associated protein-23 (CAP23, encoded by
the LOC10910172 gene in rat) increased the regeneration of
dorsal column neurons after spinal cord injury (Bomze et al.,
2001).
Based on this early success, several groups screened neurons
after peripheral nerve lesion to isolate additional, putative
RAGs. Techniques to isolate these changes include differential
display (Kiryu et al., 1995; Su et al., 1997; Kim et al., 2001;
Schmitt et al., 2003), expressed-sequence-tag (Tanabe et al.,
2000), subtractive hybridization (Mladinic et al., 2005), and
microarray (Fan et al., 2001; Bonilla et al., 2002; Costigan
et al., 2002). Modeling the utility of microarrays for gene
discovery, Bonilla and colleagues compared gene expression
of mouse DRGs with and without nerve injury and found
several genes whose expression differed between the groups
(Bonilla et al., 2002). This group then showed that one of the
gene products, small proline-rich repeat protein 1A (SPRR1A),
when overexpressed, co-localized with actin in the growth cone
and augmented axonal growth, even on inhibitory substrates.
Reduction of SPRR1A restricted neurite outgrowth in vitro. This
work highlights the utility of this approach for finding novel
RAGs.
Another paradigm used to explore CNS regeneration is
development. While adult mammalian CNS axons demonstrate
little to no regeneration after injury, axons of young neurons
may regrow (Bates and Stelzner, 1993; Hasan et al., 1993). A
key event in the developmental loss of regenerative capacity
is the postnatal myelination of long tract fibers. Evidence for
this hypothesis includes experiments showing that delaying
onset of myelination through immunological means extends
the permissive period for regeneration (Keirstead et al., 1992,
1997). However, the loss of regenerative potential is due not
only to the presence of myelin but also to the responsiveness of
neurons to myelin. In particular, many types of neurons change
their response to the myelin component myelin-associated
glycoprotein (MAG), switching from growth promotion to
inhibition during development (McKerracher et al., 1994;
Mukhopadhyay et al., 1994; DeBellard et al., 1996). In DRGs this
switch from promotion to inhibition occurs in a short period of
time at postnatal day 3–4 (Johnson et al., 1989; Mukhopadhyay
et al., 1994; DeBellard et al., 1996). A similar rapid decline
in growth is seen in DRGs plated on myelin, but not those
plated on the permissive substrate polylysine, at P2–3 (Cai et al.,
2001).
Filbin and colleagues have shown that cyclic adenosine
mono phosphate (cAMP) levels increase with conditioning
lesion (Qiu et al., 2002) and decrease during development
(Cai et al., 2001), paralleling regenerative potential. Treatment
with cAMP increases the ability of older neurons to grow on
myelin (Cai et al., 2001). The strength of the in vitro effects
are similar to that of a conditioning lesion (Qiu et al., 2002),
and intraganglionic administration of cAMP can mimic the
effect of the conditioning lesion on dorsal column axon growth
(Neumann et al., 2002; Qiu et al., 2002). Administration of
the protein kinase A (PKA) inhibitor H89 blocks the growth
of previously lesioned neurons (Qiu et al., 2002) or postnatal
day 1 (P1) neurons on myelin, and the PKA inhibitor KT5720
decreases the number P2–3 corticospinal tract axons that grow
into an embryonic tissue graft (Cai et al., 2001). The Filbin lab
also showed that the increased growth after administration of
cAMP depends on transcription, and they implicate the gene
arginase-1 as an indispensable RAG in this system (Cai et al.,
2002). It is not known whether exogenous cAMP completely
recapitulates the regenerative capacity of DRG neurons early in
development or following conditioning lesion, so we investigated
all three methods to find genes regulated in common in all three
models.
Thus, these studies probed three robust paradigms for CNS
regeneration: young developmental stage, conditioning lesion
and cAMP administration. All depend on cAMP signaling
(as evidenced by blocking the effect with PKA inhibition),
and both conditioning lesion and direct application of cAMP
require transcription to activate outgrowth. All three paradigms
are carried out in rat DRGs, cells that survive axotomy and
can be easily cultured (Coggeshall et al., 1997). We examined
gene expression differences between neurons with high growth
capacity and those with low capacity to grow in a CNS
environment. We hypothesized that gene expression differences
that are in common between each of these paradigms would
represent common and important RAGs.
Genes associated with regenerationmay function by changing
their expression levels either up or down. However, most
previously-defined RAGs have increased levels in high growth
states (e.g., GAP43, SPRR1A, and tubulin isoforms). The
approach we took to isolate common RAGs, therefore, was one
comparing the genes that were increased with cAMP treatment
and conditioning lesion and decreased during development.
These changes correspond to the changes in cAMP levels noted
by the Filbin group in each of these paradigms (Cai et al., 2001;
Qiu et al., 2002). Therefore, we were most interested in the
subsets of genes with increased expression in the cAMP and
conditioning lesion paradigms or decreased expression during
development. Results identified a large number of genes (223)
that were altered in the predicted ways by one or more of
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the regeneration paradigms. We were surprised, however, that
there was little overlap in the candidate RAGs (7 total). This
suggests the different paradigms that allow axon growth in the
CNS environment may achieve regeneration through parallel
mechanisms.
Candidate Regeneration-Associated
Genes
To validate the candidate genes, we first focused on comparison
of DRGs treated with cAMP (at 18 h) with untreated DRGs.
We targeted the validation on genes common to the three
regeneration paradigms. We also included a few genes whose
expression was strikingly divergent between the paradigms.
We compared changes in gene expression by DRGs with and
without exposure to cAMP for 18 h using both microarrays and
quantitative Polymerase Chain Reaction (qPCR), which has a
greater dynamic range. Microarray design and methods were
described previously (Carmel et al., 2004). Selected results are
shown in Figure 1. The full results of the microarrays can be
found at NIH GEO with accession numbers GSE69466 and
GSE69467.
The most striking finding was a large increase in Interleukin-
6 (IL-6) expression. At 18 h, IL-6 increased 15-fold in DRG
neurons treated with cAMP compared with untreated DRG,
as measured by qPCR. In addition, the levels of IL-6 mRNA
dramatically increased (77-fold) two days after lesion compared
to those without injury. While IL-6 had the greatest change of
any transcript for both cAMP treatment and conditioning lesion,
IL-6 mRNA levels did not change significantly during the first
five postnatal days. Due to the magnitude of the gene expression
changes with cAMP and conditioning lesion, we pursued IL-6 as
a possible RAG.
Initially described for its role in inflammation and other
immune functions, IL-6 is part of the neuropoietic family
of cytokines. This family includes ciliary neurotrophic factor
(CNTF), leukemia inhibitory factor (LIF), oncostatin M,
cardiotrophin-1, and interleukins 6 and 11. Thesemolecules bind
to specific cytokine type 1 receptors, but all members require the
common receptor gp130 for signal transduction. To determine
if the changes in IL-6 with cAMP and conditioning lesion were
limited to IL-6 or may involve other members of the gp130
family, we assayed the levels of mRNA for the cytokines and
their receptors (Figure 2). For both 18 h of cAMP treatment
(Figure 2A), and for the conditioning lesion (shown at several
time points in Figure 2B), the predominant change is in IL-6,
with more modest effects in other gp130 family members.
Subsequent experiments carried out at the Filbin laboratory
demonstrated that IL-6 is a functional RAG (Cao et al.,
2006). In addition to mRNA induction, IL-6 protein is also
FIGURE 1 | Leading mRNA changes at 18 h following dbcAMP
treatment. The top mRNAs identified by microarray (red bars),
compared with quantitative real-time PCR (qPCR, blue bars).
Cultured, dissociated cells from L4 and L5 rat DRGs were treated with
or without 1.5 mM dbcAMP for 18 h, harvested, and used to extract
total cellular RNA. For microarrays, treated samples were labeled with
one dye (Cy5) and untreated samples with another (Cy3), which were
mixed and hybridized to a spotted-oligo, glass-slide array (Carmel
et al., 2004). The dynamic range of the two-color microarray
technique is reduced compared with qPCR and more recent
technologies such as RNA-seq. Results are mean fold-change ±
SEM, n = 3, *p < 0.05 Student’s t-test.
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FIGURE 2 | mRNA levels of IL-6 family neuropoietic cytokines and their
receptors by qPCR. (A) dbcAMP treatment for 18 h. Dorsal root ganglion
(DRG) cultures were prepared and treated as described in Figure 1 and total
cellular RNA was prepared and assayed by qPCR. (B) Conditioning lesion at
three time points. The sciatic nerve was surgically transected mid-thigh at
postnatal day 20–24. After the times indicated, L4 and L5 DRG were removed
and processed for total cellular RNA and assayed by qPCR. Results are mean
fold-change SEM, n = 3, *p < 0.05 Student’s t-test.
induced in DRGs and hippocampal neurons grown on inhibitory
substrates and treated with cAMP. Administration of IL-6
protein mimics the effect of cAMP, reversing the growth
inhibition of both DRGs and hippocampal neurons grown on
inhibitory substrates. Importantly, exogenous IL-6 did not cause
increased neurite outgrowth of DRGs grown on the permissive
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substrate poly-L-lysine. This suggests that IL-6 specifically
reverses inhibition and is not due to a general trophic effect.
Importantly, intrathecal delivery of IL-6 to DRG neurons blocks
inhibition by myelin when they are explanted in vitro and in vivo,
effectively mimicking the conditioning lesion.
However, the effects of cAMP and the conditioning lesion did
not depend on IL-6. Blocking IL-6 signaling did not affect the
ability of cAMP to overcome myelin inhibitors. In addition, IL-
6-deficient mice respond to a conditioning lesion as effectively
as wild-type (wt) mice. These data suggest that IL-6 can mimic
both the cAMP effect and the conditioning lesion effect but is
not an essential component of either response. IL-6 has also been
found to promote the expression of other RAGs and to promote
neurite outgrowth of cortical neurons (Yang et al., 2012). That IL-
6 is sufficient but not necessary for axon regeneration fits with a
larger point from these studies: the regeneration paradigms seem
to act through parallel gene expression programs each of which
is effective but not reliant on the others.
The second largest change in gene expression after cAMP
administration was in secretory leukocyte protease inhibitor
(SLPI), which was also identified in a screen of gene expression
changes after spinal cord injury (Urso et al., 2007). SLPI
is a serine protease inhibitor belonging to the family of
whey acidic protein motif-containing proteins (Thompson and
Ohlsson, 1986; Eisenberg et al., 1990). Gain- and loss-of-function
studies in the Filbin lab show an essential role of SLPI in
axon regeneration (Hannila et al., 2013). SLPI can overcome
inhibition by CNSmyelin and significantly enhance regeneration
of transected retinal ganglion cell axons in rats. Furthermore,
regeneration of dorsal column axons does not occur after a
conditioning lesion in SLPI null mutant mice, indicating that
expression of SLPI is required for the conditioning lesion effect.
Thus, SLPI is both sufficient and necessary for axon regeneration
in the damaged CNS.
The final putative RAG tested by the Filbin lab is
metallothionein (MT). MTs are small cysteine-rich, zinc-
binding proteins expressed throughout the CNS. Two closely
related isoforms, MT-I and MT-II, when administered together,
promote neurite outgrowth in adult DRG’s in the presence
of myelin inhibitors (Siddiq et al., 2015). Likewise, a single
intravitreal injection of MT-I/II after optic nerve crush promotes
axonal regeneration. In contrast, adult DRGs from MT-I/II-
deficient mice extend significantly shorter processes on MAG
compared to wt DRG neurons, and regeneration of dorsal
column axons does not occur after a conditioning lesion in
MT-I/II-deficient mice. These experiments suggest that MT, like
SLPI, is both necessary and sufficient for axon regeneration in
the CNS.
Additional Candidate Genes
Several additional transcripts were identified but we have not
yet pursued their roles in regeneration. For example, VGF
encodes a secretory-peptide precursor involved in plasticity and
metabolism. VGF is modulated in vivo by paradigms which
lead to neurotrophin induction, synaptic remodeling and axonal
sprouting (Snyder et al., 1998a). VGF shows greatest expression
during times of axonal outgrowth and synaptogenesis in the
developing brain (Lombardo et al., 1995; Benson and Salton,
1996; Snyder et al., 1998b). Mouse VGF knockouts (KO) are
small, hypermetabolic, and have reduced leptin levels, suggesting
a prominent role in energy metabolism (Hahm et al., 1999).
These findings provide evidence for a neurotrophic role for VGF,
in addition to its function as neuroendocrine molecule.
The cAMP responsive event modulator (CREM) gene
encodes both antagonists and activators of the cAMP-dependent
transcriptional response by alternative splicing (for review see
Della Fazia et al., 1997). CREM is inducible by activation of the
cAMP signaling pathway with the kinetics of an early response
gene. An alternatively splice repressor form, inducible cAMP
early repressor (ICER), may be important for the transient nature
of cAMP-induced gene expression. The role of this molecule in
regenerative signaling remains to be determined.
We found two genes, ATF3 and GAP43, whose expression
differed markedly between cAMP treatment and conditioning
lesion. These differences suggest possible differences in
mechanism between these pro-regenerative paradigms. ATF3
is part of the activating transcription factor/CREB family
of transcription factors. The gene encodes a leucine zipper
transcription factor (Hsu et al., 1991) that is increased by cellular
stress (reviewed in Hai et al., 1999). ATF3 is strongly induced
by sciatic nerve lesion in dorsal root ganglia and spinal motor
neurons (Tsujino et al., 2000) and in the geniculate ganglion after
chorda tympani injury (Tsuzuki et al., 2002). ATF3 represses
transcription as a homodimer (Chen et al., 1994) and activates
transcription as a heterodimer with cJun (Hai and Curran,
1991; Chu et al., 1994). Jun has been investigated as a RAG
(Broude et al., 1997; Houle et al., 1998; Lerch et al., 2014), and
the possibility of cJun and ATF3 acting as inducers of RAG
expression has been validated in DRG (Seijffers et al., 2007).
Whether ATF3 might be acting as a transcriptional activator or
repressor in these models must be investigated further.
Surprisingly, GAP43 expression decreased in our cAMP
model (Figure 1). GAP43 is the prototypical RAG and is often
used as a marker for regenerating axons (Benowitz et al., 1990).
Schreyer and colleagues have previously shown that GAP43
may be repressed by cAMP (Andersen et al., 2000a,b). In a
search for the signal that causes DRG neurons to downregulate
GAP43 after they reach their targets, this group found decreases
on both the mRNA and protein levels in cAMP-exposed DRG
neurons. Interestingly, exposure of rat cortical neurons to
spinal cord extract, but not extract from cerebellum or muscle,
was sufficient to decrease GAP43, and this repression was
adenyl cyclase-dependent (Karimi-Abdolrezaee and Schreyer,
2002). The finding of increased neurite outgrowth associated
with GAP43 repression challenged the widespread notion that
regeneration is accompanied by GAP43 induction. This has
subsequently been shown in other models of regeneration, such
as following cJun activation of axon growth (Lerch et al., 2014).
Implications
These studies produced three surprising results. First, we found
little overlap in the gene expression changes produced by the
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three regeneration paradigms we studied. Although the neurons
in each of these models all express high levels of cAMP in the
regenerative state, the changes in transcription differ markedly.
Rather than uncovering a core regeneration program that allows
a switch from inhibition to growth in the CNS environment, we
found different transcriptional changes, each leading to a similar
regenerative phenotype. This suggests the existence of several
transcriptional programs with overlapping function.
Second, we found that the first three transcripts studied
are each sufficient to elicit regeneration in vivo. In addition,
both SLPI and MT are necessary for the regeneration induced
by cAMP or conditioning lesion. This remarkable ‘‘hit rate’’
could be serendipity, or it could tell us that regeneration may
not require a coordinated program requiring multiple gene
products. It could be that IL-6, SLPI, and MT all create a
coordinated cellular response of several pathways. But it is
heartening that regeneration can be produced with each of these
varied approaches as monotherapy. Whether the effects of these
therapies in combination would be more effective is a critical
question for future study. In addition, in the animal studies done
so far, no loss of function has been done in CNS resident neurons.
But these experiments are more difficult since CNS neurons
do not regeneration spontaneously, thus requiring the use of a
regeneration competent background (e.g., PTEN deletion, as has
been done for DLK with the optic nerve injury model; (Watkins
et al., 2013). Finally, the function of the regenerated axons has
not yet been tested by measures of physiology or behavior.
Finally, the gene for GAP43, critical to regeneration after
conditioning lesion, is strongly downregulated by cAMP
treatment. This evidence argues strongly that these different
regenerative paradigms act through diverse transcriptional
programs. Rather than a single path to successful regeneration,
many possible transcriptional changes may lead to re-growth.
Mapping these paths will be critical to flipping the transcriptional
switch from inhibition to growth in the CNS.
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